Filip Cvetkovski

Affiliations
  • Research and Development, ITB-Med AB, Stockholm, Sweden.

Publications (6)

Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity.

Frontiers in immunology
Avec: Christian Binder , Felix Sellberg , Filip Cvetkovski , Stefan Berg , Erik Berglund , David Berglund

CD2 Immunobiology.

Frontiers in immunology
Avec: Christian Binder , Filip Cvetkovski , Felix Sellberg , Stefan Berg , Horacio Paternina Visbal , David H Sachs , Erik Berglund , David Berglund

Strategies for Liver Transplantation Tolerance.

International journal of molecular sciences
Avec: Filip Cvetkovski , J Mark Hexham , Erik Berglund

Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin

Frontiers in immunology
Avec: Christian Binder , Felix Sellberg , Filip Cvetkovski , Erik Berglund , David Berglund

Evaluation of Spin Columns for Human Plasma Depletion to Facilitate MS-Based Proteomics Analysis of Plasma.

Journal of proteome research
Avec: Xiaofang Cao , AnnSofi Sandberg , José Eduardo Araújo , Filip Cvetkovski , Erik Berglund , Lars E Eriksson , Maria Pernemalm

Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Avec: Filip Cvetkovski , Ronia Razavi , Felix Sellberg , Erik Berglund , David Berglund

Réseau de co-auteurs

Erik Berglund 6 collaborations
Felix Sellberg 4 collaborations
David Berglund 4 collaborations
Christian Binder 3 collaborations
Stefan Berg 2 collaborations
Horacio Paternina Visbal 1 collaboration
David H Sachs 1 collaboration
J Mark Hexham 1 collaboration
Xiaofang Cao 1 collaboration
AnnSofi Sandberg 1 collaboration
José Eduardo Araújo 1 collaboration
Lars E Eriksson 1 collaboration
Maria Pernemalm 1 collaboration
Ronia Razavi 1 collaboration